Seltorexant, in combination with an oral antidepressant, demonstrated a numerically greater response rate at week 26 with a more favorable safety and tolerability profile compared to adjunctive quetiapine XR Patients… Read More
Switzerland, Allschwil – Idorsia Ltd. announces that Simcere Pharmaceuticals Group Ltd (2096.HK, “Simcere”) has launched QUVIVIQ® (daridorexant) in China. QUVIVIQ, Idorsia’s dual orexin receptor antagonist, is indicated for the treatment of adult… Read More
FRANKLIN LAKES, N.J. – BD (Becton, Dickinson and Company) a leading global medical technology company, announced a pharmacy automation partnership with Henry Ford Health to develop the health system pharmacy of the… Read More
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C. – United Therapeutics Corporation announced that it will host a webcast to review data from the successful TETON-2 pivotal study evaluating the use of… Read More
Genome BC has announced funding for four new UBC research projects associated with Canada’s Immuno-Engineering and Biomanufacturing Hub (CIEBH), a UBC-led national initiative aimed at accelerating the development of lifesaving… Read More
